Flagship · Bulletin

Macro rationale

Patch/event-driven run — regime unchanged at NEUTRAL with defensive lean, per the macro digest. Credit tight (HY OAS 2.71, below 90d sma), VIX only +4.5% vs 200d, but the extension escalator is ACTIVE (QQQ +12.65% >200d) so cash holds the upper band rather than the floor. Warsh Fed delivered a hawkish hold (dot median 3.8%, CME Sept-hike odds 72.8%, BofA modeling 75bp of 2026 hikes) against 4.2% headline CPI and record-narrow equity leadership — a downside asymmetry that keeps cash near the mid-band. The midweek trigger does not change the regime; it surfaces (1) MU +12.75% on a blockbuster Q3 HBM print (accelerating flow), and (2) NVDA/ASML/AVGO score drift >15pts which is multiple compression on rising 10y, not a thesis break. No policy item landed for any pillar this week, so direction stays neutral.

Thesis

Event-driven patch run, scoped to [ASML, AVGO, KTOS, MU, NVDA, TSM, ANET, FN, HEI, PSN]; all other names held unchanged per the trigger. The midweek check surfaced four facts and I acted on exactly one. (1) MU printed a blockbuster Q3 and ran +12.75% (verified $1,048) on confirmed HBM/Anthropic demand — the one clean accelerating flow this week — so I added 1.5pp to an underweight 2.57% slot (4.07%), funded from cash to 9.2% (inside the NEUTRAL band). (2) NVDA (-16), ASML (-22), AVGO (-16) score drift is multiple compression on the hawkish-Warsh 10y, not a durability or flow break — CUDA/$725B capex, the EUV monopoly, and the 70%-share ASIC book are all intact, so the mandate is HOLD, not auto-trim on score drift. (3) KTOS -5.61% is Iran-ceasefire sentiment on defense demand; the MACH-TB $1.45B IDIQ and the FY27 DAWG $54.6B / 200k-drone program are structurally unaffected — held. (4) HEI/PSN/FN/ANET/TSM carry no fresh trigger and stay flat; PSN's sub-60 score sits under a lock (unlock=none) with no broken verdict, so it holds to the book-to-bill test. No churn: one add, sixteen holds.

Reflection

MU's +12.75% earnings pop is the lone accelerating AI flow this week; NVDA/ASML/AVGO score drift is rate-driven multiple compression, not a flow reversal — hold the franchises.

The midweek trigger is a useful stress-test of the hold-through-drift discipline: three compute anchors slid >15 score pts in a quiet-policy week, and the reflexive move would be to trim toward the brief's compute-underweight. But the named funders (EUV monopoly, $725B capex, 70% ASIC share) are all intact — this is the discount rate, not demand. MU confirms the underlying flow is fine. Tension I'm carrying: the book is stuck at 17 positions (below the 18-20 band) and the patch scope forbids opening anything outside the named list to fix it — that count gap has to be closed at the next full Su

Positions (17)

• TSMTaiwan Semiconductor Manufacturingcompute

  hold8.43%83
  flow steadyconf

  Funder

  Leading-edge foundry monopoly (<3nm), >50% gross margin, prodigious FCF, disciplined capex — routes the world's AI silicon for decades. Goldman's $920B-$1.4T 2027 AI-capex forecast names TSMC explicitly; CHIPS $6.6B Arizona disbursement locked; NVDA/AMD/AAPL/AVGO leading-edge silicon flows exclusively through TSMC sub-3nm; Norway GPFG holds.

  Unwind

  Leading-edge node-share loss to Intel 18A/Samsung, a multi-quarter AI-capex cut from hyperscalers, or material Apple-Intel volume migration off TSMC at advanced nodes.

  Catalyst

  Q2 FY2026 earnings (late July) — 3nm utilization and capex guide.

• NVDANVIDIAcompute

  hold4.29%72
  flow softeningconf

  Funder

  CUDA/accelerator software moat, ~75% gross margin, fortress balance sheet. ~$725B 2026 hyperscaler capex anchored on Blackwell/Rubin (MSFT $190B, AMZN $200B, GOOGL $180-190B, META $125-145B); Stargate $500B JV; 74% inference share and record Q1 FY2027 data-center revenue confirm no fundamental break.

  Unwind

  Data-center revenue <20% of mix or ASIC share >25% for two consecutive quarters, or a named hyperscaler capex cut. Score drift to 72 is valuation/ASIC-competition noise, not the break.

  Catalyst

  Next earnings — consecutive-quarter data-center growth test.

• ASMLASML Holdingcompute

  hold4.00%63
  flow softeningconf

  Funder

  EUV lithography monopoly — the single most irreplaceable tool in advanced semis, ~50% gross margin, multi-year backlog, no commercial-scale alternative. Norway GPFG holds, Coatue/Third Point added Q1; TSMC/Samsung/SMIC 2025-27 EUV orderbook backstops cash flow.

  Unwind

  A China export-control expansion that materially craters bookings, or a high-NA EUV order-cancellation wave. Score collapse to 63 is multiple compression on rising 10y yields, not a bookings break — held through it.

  Catalyst

  Q2 bookings print — clean China/EUV order read to restore score >70.

• AVGOBroadcomcompute

  hold3.33%62
  flow softeningconf

  Funder

  Custom-silicon ASIC leader (~70% share) + VMware software, huge FCF, $7B+ annual buyback, serial dividend grower. GOOG TPU multi-gen, META MTIA, Anthropic 3.5GW ASIC contracts; Q2 confirmed AI segment +143% to $10.8B and $30B+ bookings; Tiger Global added Q1.

  Unwind

  AI semi revenue falling below the ~$25B annual run-rate, or hyperscaler ASIC insourcing displacing AVGO designs. Score 62 is the NVDA-74%-inference framing noise, not a contract loss.

  Catalyst

  Next quarter — custom AI chip revenue trajectory vs $25B run-rate floor.

• ANETArista Networkscompute

  hold2.86%67
  flow steadyconf

  Funder

  Durable hyperscaler-networking franchise, share-gainer since 2004, ~65% gross margin, net cash, single-image EOS software moat, Ullal-led capital discipline. Microsoft & Meta named as largest customers funding 35% YoY revenue growth; Morgan Stanley raised PT to $190 (Jun 12).

  Unwind

  Hyperscaler share loss to white-box/NVDA Spectrum networking, or a bookings break confirming the post-earnings demand-normalization fear. Lock 16d, unlock=none.

  Catalyst

  Next earnings — AI Ethernet bookings vs hyperscaler-loss narrative.

• MUMicron Technologycompute

  hold3.76%77
  flow acceleratingconf

  Funder

  US HBM3e/HBM4 supplier in a capacity-disciplined memory cycle, sold out through 2026-27. Anthropic multi-year supply agreement signed 6/22; ~$725B 2026 hyperscaler capex; Goldman names memory one of three critical AI-infrastructure beneficiaries. Q3 print today drove +12.75% (verified $1,048) confirming blockbuster AI/HBM demand — the cleanest accelerating flow in scope.

  Unwind

  HBM ASP collapse / broad memory oversupply, or Samsung/SK Hynix taking decisive HBM4 share. The Korea-contagion wobble (Samsung/SK -12%) was macro noise, not a Micron demand break.

  Catalyst

  Just-reported Q3 confirmed HBM ramp; next fiscal Q4 print and HBM4 qualification milestones.

• FNcompute

  hold2.04%63
  flow softeningconf

  Funder

  Optical transceiver/packaging manufacturer interconnecting hyperscaler AI clusters; capital-light, debt-free, extracts hyperscaler capex without silicon R&D risk. AWS dominant customer drove ~35.9% YoY growth; 800G/1.6T demand from NVDA/AMD GPU clusters; Q3 FY26 rev $1.21B and EPS $3.72 both beat.

  Unwind

  Hyperscaler optical insourcing, a 1.6T ramp delay, or Datacom-segment sequential decline confirming demand normalization. May-4 sell-the-news was sentiment, not a break. Lock 7d, unlock=none.

  Catalyst

  Next Datacom segment sequential print — 800G/1.6T ramp confirmation.

• CCJCamecoenergy

  hold7.51%65
  flow steadyconf

  Funder

  Tier-1 Saskatchewan uranium franchise + Westinghouse 49% JV with Brookfield; commodity tail-risk hedge slot. Utility contract book at $60+/lb vs term market ~$93/lb; Kazatomprom 8Mlb output cut sustains structural deficit; 75 reactors under construction; AI-DC nuclear PPA rush.

  Unwind

  Uranium term-price break below contract economics, reactor-build cancellations, or a Westinghouse JV write-down. Out of patch scope — hold-unchanged.

  Catalyst

  Next quarterly — contract book additions and uranium term price.

• GEVGE Vernovaenergy

  hold8.93%63
  flow steadyconf

  Funder

  Gas-turbine + grid franchise with pricing power — ~$163B backlog sold through 2028, 100GW turbine backlog, 10-20% price realization. The brief's favored grid/electrification pick. Norway GPFG added post-spin; hyperscaler grid pull-through; Goldman flags GEV as the AI-capex grid bottleneck.

  Unwind

  AI-load grid capex cut, wind-segment loss reacceleration, or backlog cancellations. Out of patch scope — hold-unchanged.

  Catalyst

  Next earnings — order-book disclosure and turbine slot reservations.

• SCCOSouthern Copperenergy

  hold6.95%63
  flow steadyconf

  Funder

  Lowest-cost copper producer, vast reserves, fat margins, large dividend; commodity tail-risk hedge slot. Copper at all-time highs >$6.50/lb (vs $5 entry trigger); AI/data-center ~30% of new copper demand by 2030 (BloombergNEF); BHP copper now exceeds iron-ore profit.

  Unwind

  Copper price collapse below ~$4/lb or a China-demand break that erases the structural deficit. Lock 2d, unlock=none. Out of patch scope — hold-unchanged.

  Catalyst

  Tia Maria/Los Chancas permitting update; copper price action.

• MPMP Materialsenergy

  hold6.14%
  flow steadyconf

  Funder

  Only scaled US rare-earth + magnet producer, DoD-backstopped moat vs China's ~98% magnet control. DoD $400M Series A preferred + $150M loan + 10-yr NdPr price floor + 10-yr magnet offtake for the 10X facility; MOFCOM No.23 (6/22) controls underscore the ex-China-capacity tailwind.

  Unwind

  TTM FCF stays negative with magnet-segment ramp stalling, or the DoD price-floor/offtake is amended. Lock 2d, unlock=none. Out of patch scope — hold-unchanged.

  Catalyst

  Next quarterly — TTM FCF turn and magnet-ramp metrics.

• NEMNewmont Corporationenergy

  hold5.02%87
  flow softeningconf

  Funder

  Tail-risk equity hedge (§5.3/10.2): largest gold producer, tier-1 long-life assets, strong post-Newcrest FCF and dividend, improving cost discipline. Central-bank gold accumulation; structural hedge against a frozen-Fed stagflation regime. Score 87 — highest in the energy pillar.

  Unwind

  Sustained gold break below bear-market lows with no central-bank bid, or a cost/operational blowout. Gold's -25% bear market softens the tailwind but the hedge role is intact. Lock 21d, unlock=none.

  Catalyst

  Gold price stabilization above bear-market lows; next quarterly cost print.

• KTOSKratos Defensedefense

  hold10.05%
  flow steadyconf

  Funder

  Tactical drones (XQ-58 Valkyrie), hypersonics, turbine engines — DAWG-adjacent defense-tech. DoD MACH-TB 2.0 $1.45B IDIQ ceiling, Project Helios $68.3M, USMC Valkyrie mods; SpaceX IPO + OpenSpace satellite ground-system growth. FY27 DAWG $54.6B line + 200k-system Drone Dominance program is the structural funder.

  Unwind

  DAWG/Drone-Dominance funding cut in reconciliation, or a Valkyrie/MACH-TB program loss. The -5.61% is Iran-ceasefire sentiment on defense demand, not a contract cancellation — held through it. Lock 2d, unlock=none.

  Catalyst

  Q2 earnings — revenue scale/margin confirmation; NDAA reconciliation markup.

• HEIHEICOdefense

  hold11.88%68
  flow steadyconf

  Funder

  Defense/aero aftermarket compounder — Mendelson family owners since 1957, 20%+ FCF CAGR, disciplined serial acquirer ($1B+/yr). Q2 beat FSG $929M vs $864M, ETG $460M vs $396M; NDAA mandatory funding + commercial aerospace MRO. Textbook 20-30yr franchise.

  Unwind

  Commercial MRO demand collapse, a value-destroying large acquisition, or organic growth stall. 54x forward P/E is a valuation watch but growth is intact — not a trim trigger on its own. Lock 2d, unlock=none.

  Catalyst

  Next quarterly — organic FSG/ETG growth and acquisition tape.

• PSNdefense

  hold2.01%50
  flow softeningconf

  Funder

  C5ISR/cyber government-services prime, sticky multi-year IDIQ backlog. MDA SHIELD $151B-ceiling IDIQ, DTRA cyber $137M, USAF MATOC $15B, Navy WEXMAC $10B — all prime awards per Parsons IR; $1.1-1.4B Blatnik Bridge win (6/16).

  Unwind

  Book-to-bill confirmed <1.0 next quarter with task-order pace continuing to lag. Score 50 is weakening but lock 13d unlock=none and no broken verdict — held to the book-to-bill test.

  Catalyst

  Next quarter book-to-bill — >1.0 recovery is the confirm/break line.

• LLYEli Lillybiology

  hold2.50%70
  flow steadyconf

  Funder

  Premier pharma compounder — Mounjaro/Zepbound GLP-1 franchise + retatrutide Ph3 (~70lb loss) extends a multi-decade runway, deep margins, strong capital return. Profitable and cash-generative, insulated from the rate vise. Norway GPFG/large AM holders.

  Unwind

  GLP-1 share loss to a next-gen rival, a retatrutide pipeline failure, or a CMS drug-pricing shock. Lock 28d, unlock=none. Out of patch scope — hold-unchanged.

  Catalyst

  Retatrutide Ph3 readouts; CMS/drug-pricing policy developments.

• VRTXVertex Pharmaceuticalsbiology

  hold2.18%76
  flow steadyconf

  Funder

  CF monopoly (Trikafta) cash engine, self-funded, high margins; Casgevy gene therapy + suzetrigine (Journavx) non-opioid pain optionality. Profitable, insulated from the rate vise. Norway GPFG/large AM holders; Casgevy pediatric expansion.

  Unwind

  CF franchise erosion, a Journavx launch failure, or pipeline setback in pain/kidney. Lock 28d, unlock=none. Out of patch scope — hold-unchanged.

  Catalyst

  Journavx launch trajectory; pipeline (CTX-anticoagulant, kidney) readouts.

Warnings

• stale_policy guard: MU add → hold (delta zeroed)
• tilt_truncated: biology tilt -5pp truncated at 0% cap
• §2 cap re-applied after pillar tilt: HEI
• position_count: 17 < 18 after mechanical closes (§2 floor) — book under-populated; strategist must open replacements next run
• ledger stale (ledger over-bought (cash -36.25% of NAV)) — rebalance diffed against intent

Conviction-lock actions

1. Turn 1ConvictionGuard (§6.5d)

   —
2. Turn 2ConvictionGuard (§6.5d)

   —

Cost breakdown

Per-call cost computed from cost.js pricing constants (Opus 4.7, Sonnet 4.6, Haiku 4.5). Cache-read tokens billed at 10% of input. See Cost & ROI for the rolling 30-day ledger.